Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Scare over infected Indian blood stocks:

This article was originally published in Clinica

Executive Summary

Almost a third of blood supplies in Indian banks is suspected to be infected with HIV, hepatitis or malaria. The majority of the country's blood banks do not screen blood because of the lack of imported kits and non-functioning apparatus, reports Nature Medicine. However, a rapid HIV kit being developed at Delhi University (see Clinica No 675, p16) by Dr Vijay Chaudhary hopes to reduce the problem. The single-step kit, which is still to be marketed, provides results in less than 10 minutes using a single drop of blood. The Indian government has already spent $100,000 on Dr Chaudhary's work, with a further $150,000 to be made available for developing fusion proteins used in the test.

Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

MT094544

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel